Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||Advanced Solid Tumor||not applicable||CC-122||Phase I||Actionable||In a Phase I trial, Avadomide (CC-122) treatment was well tolerated in patients with advanced solid tumors (n=27) but did not result in any objective responses in patients with advanced solid tumors other than brain cancer (n=19), stable disease was observed in 2 patients (lasting 114 and 309 days) with hepatocellular carcinoma (PMID: 30201761; NCT01421524).||30201761|